Download Please refer to the case below to answer the following survey

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Macropsia wikipedia , lookup

Phantosmia wikipedia , lookup

Hemiparesis wikipedia , lookup

Management of multiple sclerosis wikipedia , lookup

Transcript
Case Studies in COPD Management
Please refer to the case below to answer the following survey questions.
TR is a 68 year old male who presents to the emergency room with a chief complaint of shortness of breath. His
symptoms have increased over the past 4 days causing him to use his albuterol inhaler more frequently. Despite the
increased use of his rescue inhaler, he has been short of breath and fatigued with an increase in discolored sputum
production. He denies fever, chest pain, weakness, nausea, vomiting, diarrhea or constipation. He reports no sick
contacts or recent travel. He has 2 other similar hospitalizations within the last year.
PMH:
COPD
Hypercholesterolemia
HTN
HF
GERD
Atrial fibrillation
Anxiety
FH:
Father deceased at age 85; heart attack
Mother deceased at age 87; Stroke
Brother age 65; HTN, hypercholesterolemia
Sister age 64; HTN, hypercholesterolemia
SH:
Retired fireman. Married and lives with wife and has 2 children who live nearby and are helpful with their parent’s
healthcare and needs.
Smoked 1 ½ packs of cigarettes daily for 20 years. He cut back to 1 pack daily for a year before attempting to quit 2
months ago.
He drinks beer socially; 1-2 beers a week.
No known allergies.
Home Medications:
Albuterol MDI Inhale 2 puffs q 4h as needed for SOB
Fluticasone / Salmeterol 250mcg / 50mcg 1 inhalation BID
Tiotropium 18mcg 1 inhalation daily
Atorvastatin 40mg po daily
Buspirone 20mg po daily
Lisinopril 20 mg po daily
Warfarin 2.5mg po MWF, 5mg TTSS
Fish oil 1000mg 1 capsule po daily
Multivitamin 1 po daily
Omeprazole 20 mg po daily
Nicotine gum 2mg as needed.
Acetaminophen 500mg po q4 hours as needed for pain/headache
PE:
TR is a pleasant gentleman in moderate respiratory distress.
BP: 137/78
HR: 96
RR: 25
T: 99.5 F
Ht: 72 inches
Wt: 185 lbs
Skin: Dry, warm
HEENT: PERRLA, EOMI; patches of white inside mouth
Neck: No lymphadenopathy, thyromegaly or bruits. Mild JVD. Use of accessory muscles for breathing.
Chest: No rales or crackles. Ronchi noted. Bilateral wheeze on inspiration and expiration. Barrel shaped chest.
CV: Irregularly irregular rhythm, no murmurs, rubs or gallops
Abdomen: nontender, nondistended; paradoxical abdominal motion
Neurology: A&Ox3, cranial nerves intact
Extremities: cool, no clubbing. +1 edema of lower legs.
Using the above case, please answer the following questions:
1. Which of the following is/are risk factor(s) which may have contributed to TR’s COPD diagnosis?
a. Cigarette smoking
b. Increased physical activity
c. Environmental exposures
d. A and C
2. Fluticasone/Salmeterol Diskus is a:
a. Dry powder inhaler
b. Metered dose inhaler
c. Nebulized solution
d. HFA inhaler
3. Patients with an infectious exacerbation of severe COPD are at risk for which pathogens:
a. Pseudomonas
b. H. influenzae
c. S. pneumoniae
d. M. catarrhalis
e. All of the above
4. The most effective thing TR could do at this point to slow his COPD progression is:
a. Better compliance with medications
b. Treat his anxiety
c. Stop smoking
d. Loose weight
5. A Pulmonary rehab program is only indicated in severe COPD
a. True
b. False
6. Based on TR’s complaints and only having a mild fever:
a. Antibiotics are not indicated
b. Antibiotics are indicated
c. His exacerbation is most likely viral
d. A chest X-ray will better clarify the need for antibiotics
7. TR’s current medication treatment for anxiety:
a. Should be discontinued because of the side effect of decreasing respiratory drive
b. Is a reasonable choice in COPD patients
c. Is generally more effective/preferred over the SNRI’s class of medications
d. He is not on any anti-anxiety medications
8. TR’s reported level of alcohol intake:
a. Is a significant risk factor in further exacerbations
b. Will complicate pulmonary rehab efforts
c. Is contraindicated in patients receiving warfarin
d. Has little to no impact on his COPD
9. Patients at high risk for future exacerbations have:
a. A history of 2 or more exacerbations within the previous year
b. A GOLD level of 2 or greater for COPD severity of disease
c. A GOLD level of 4 for COPD severity of disease
d. A and B
10. Patients may respond to the “Righting Reflex” with defensiveness and resistance to change
a. True
b. False